Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garraway

Showing results (391-400 of 549) with videos related to

Pageof 55
Sort By:
Molecular Cell|August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate OncogenesisGabriel J Sandoval, John L Pulice, Hubert Pakula, et al.
Cancer Research|February 5, 2008
Modeling genomic diversity and tumor dependency in malignant melanomaWilliam M Lin, Alissa C Baker, Rameen Beroukhim, et al.
JAMA Surgery|July 16, 2025
Clinical Practice Guideline Recommendations on Mental Health in Trauma: A Systematic ReviewMélanie Bérubé, Alexandra Lapierre, William Panenka, et al.
Science (New York, N.Y.)|April 28, 2022
Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironmentEran Hodis, Elena Torlai Triglia, John Y H Kwon, et al.
NEJM Evidence|May 30, 2024
Prostate Cancer Foundation Screening Guidelines for Black Men in the United StatesIsla P Garraway, Sigrid V Carlsson, Yaw A Nyame, et al.
Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.
Cancer Research|March 3, 2025
Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFRMartin L Sos, Mirjam Koker, Barbara A Weir, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2011
Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomasYongji Tian, Benjamin E Rich, Natalie Vena, et al.
Cancer Research|April 9, 2009
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFRMartin L Sos, Mirjam Koker, Barbara A Weir, et al.
Nature Biotechnology|June 23, 2014
Assessing the clinical utility of cancer genomic and proteomic data across tumor typesYuan Yuan, Eliezer M Van Allen, Larsson Omberg, et al.
Pageof 55

Showing results (391-400 of 549) with videos related to

Sort By:
Pageof 55
Molecular Cell|August 7, 2018
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate OncogenesisGabriel J Sandoval, John L Pulice, Hubert Pakula, et al.
Cancer Research|February 5, 2008
Modeling genomic diversity and tumor dependency in malignant melanomaWilliam M Lin, Alissa C Baker, Rameen Beroukhim, et al.
JAMA Surgery|July 16, 2025
Clinical Practice Guideline Recommendations on Mental Health in Trauma: A Systematic ReviewMélanie Bérubé, Alexandra Lapierre, William Panenka, et al.
Science (New York, N.Y.)|April 28, 2022
Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironmentEran Hodis, Elena Torlai Triglia, John Y H Kwon, et al.
NEJM Evidence|May 30, 2024
Prostate Cancer Foundation Screening Guidelines for Black Men in the United StatesIsla P Garraway, Sigrid V Carlsson, Yaw A Nyame, et al.
Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.
Cancer Research|March 3, 2025
Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFRMartin L Sos, Mirjam Koker, Barbara A Weir, et al.
The Journal of Molecular Diagnostics : JMD|September 3, 2011
Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomasYongji Tian, Benjamin E Rich, Natalie Vena, et al.
Cancer Research|April 9, 2009
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFRMartin L Sos, Mirjam Koker, Barbara A Weir, et al.
Nature Biotechnology|June 23, 2014
Assessing the clinical utility of cancer genomic and proteomic data across tumor typesYuan Yuan, Eliezer M Van Allen, Larsson Omberg, et al.
Pageof 55